Study of CYR-101 in Patients With Schizophrenia
NCT00861796
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
100
Enrollment
INDUSTRY
Sponsor class
Conditions
Schizophrenia
Interventions
DRUG:
CYR-101
DRUG:
Placebo
Sponsor
Cyrenaic Pharmaceuticals